By Dr. Rajesh R
The World Retinoblastoma Awareness Week is observed every year in May. This year it falls between May 8-14, when healthcare providers around the world come together to create public awareness about retinoblastoma. It is the most common and life-threatening eye cancer in children, less than five years of age. It can affect any socio-economic group without any racial or gender preference. It can affect either one or both eyes. It is a type of eye cancer that begins in the retina the sensitive lining inside the eye. It is quite rare and is usually caused by a genetic mutation that makes the cells in the eye multiply rapidly and thereby forming an abnormal growth. With improved techniques, the survival of children with Retinoblastoma has improved but low awareness is still a cause of concern. Hence early detection and treatment is vital to control the malignant growth, thereby saving the vision and childs life.
Every year, almost 1 in 10,000 live births in the world has retinoblastoma and India has been proposed to have 3 times this global average and recorded as the highest number of affected children in the world. While the survival rate for retinoblastoma is over 95% in the developed countries, it is around 40-75% in developing nations like India due to a combination of multiple factors like poverty, illiteracy, lack of awareness, delay in seeking medical attention, and lack of access to healthcare resources. The care of retinoblastoma children during the pandemic was challenging as the nationwide lockdown had deprived retinoblastoma patients of optimal management. The entire impact of the pandemic on retinoblastoma management is still not known, but it is important to increase awareness of the timeliness of diagnosis and treatment.
SYMPTOMS
Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. At early stages, the symptoms might be very subtle due to which the child may seem fit, but delay in diagnosing retinoblastoma can lead to advanced stages at presentation which may necessitate prompt removal of the affected eye. The most common presentation of this disease is with abnormal light reflex white eye, or cats eye reflex noted usually by neighbours or relatives. This is easily identified using flashlight photography seen as a white reflex. Crossed eyes or squint, swelling, irritation and endless watering are other common symptoms. The vision is lost rapidly and the child might frequently bump into objects and get hurt. There are other eye diseases which may present with similar signs and symptoms as retinoblastoma. This has to be confirmed after evaluation by an ocular oncologist.
DIAGNOSIS &TREATMENT
When diagnosed early there is good chance of both vision and eye-ball preservation. In some cases, when diagnosed late, the eye-ball might have to be removed to prevent spread of the cancer in the whole body. Scans and other imaging tests can help your childs doctor determine whether retinoblastoma has grown to affect other structures around the eye. With advanced chemotherapy techniques and local forms of therapy, we are able to preserve vision also in many cases. Retinoblastoma requires multidisciplinary coordinated care, and it requires involvement of multiples specialties, including ophthalmology, oncology, radiology, genetics, anaesthetist and others.
PREVENTION
Since retinoblastoma is inherited mostly from the genes, there are no fixed measures of prevention. But keeping optimal care of your eyes on a regular basis may help reduce the risk. Awareness on retinoblastoma is very crucial, especially when the world is amidst a pandemic. Many patients have reported eye infections post-covid and that should not be neglected. Eye infections might look like a small issue, but if not treated can turn fatal, hence we should always indulge in regular medical check-ups, particularly for children as precaution is always better than cure.
It is important to note that there is a chance of the cancer returning even after completing the treatment for retinoblastoma. Furthermore, children who have inherited this genetic mutation have a high chance of developing cancer in other parts of their body as well, hence regular follow-ups and screening is essential.
(The author is Consultant, Vitreoretina and Ocular Oncology Sankara Eye Hospital, Bangalore. The article is for informational purposes only. Please consult medical experts and health professionals before starting any therapy, medication and/or remedy. Views expressed are personal and do not reflect the official position or policy of the FinancialExpress.com.)
See original here:
Retinoblastoma among children: Early detection and treatment are vital - The Financial Express
- 001 Adverum Biotechnologies Proceeds with IND Amendment for ADVM-022 Phase 2 Trial in Wet AMD After Receiving Requested Type C Meeting Feedback from the... [Last Updated On: April 11th, 2022] [Originally Added On: April 11th, 2022]
- 002 PFE: 5 Global Healthcare Stocks to Buy as BofA Warns of a - StockNews.com [Last Updated On: April 11th, 2022] [Originally Added On: April 11th, 2022]
- 003 Christian group prepares legal challenge over conversion therapy ban - The Telegraph [Last Updated On: April 11th, 2022] [Originally Added On: April 11th, 2022]
- 004 Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative - Yahoo Finance [Last Updated On: April 11th, 2022] [Originally Added On: April 11th, 2022]
- 005 How Diabetes can be a driver for High blood pressure and eventually leads to Hypertension - APN News [Last Updated On: May 20th, 2022] [Originally Added On: May 20th, 2022]
- 006 GenSight Biologics Announces Publication of a Study of the Impact of LHON Disease on the Lives of Patients and Relatives in Journal of... [Last Updated On: May 20th, 2022] [Originally Added On: May 20th, 2022]
- 007 Capsida, Adverum, Instil and Metagenomi Showcase Therapies at ASGCT - BioSpace [Last Updated On: May 20th, 2022] [Originally Added On: May 20th, 2022]
- 008 Myrtelle Enters into a Worldwide Exclusive License Agreement with Rescue Hearing to Develop and Commercialize Gene Therapy for the Treatment of... [Last Updated On: May 20th, 2022] [Originally Added On: May 20th, 2022]
- 009 How the Pandemic is Taking a Toll on Rhode Island's Front-Line Health Care Workers - Rhode Island Monthly [Last Updated On: May 20th, 2022] [Originally Added On: May 20th, 2022]
- 010 Qlaris Bio Reports Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile and Positive Efficacy Signal for QLS-101 -... [Last Updated On: May 20th, 2022] [Originally Added On: May 20th, 2022]
- 011 Perceive Biotherapeutics Appoints Anne E. Fung MD, as Chief Medical Officer to Drive Transformational Clinical Programs - PR Newswire [Last Updated On: May 20th, 2022] [Originally Added On: May 20th, 2022]
- 012 Adverum Biotechnologies Presents Best-Corrected Visual Acuity and Central Subfield Thickness Analyses After a Single IVT Injection of ADVM-022... [Last Updated On: July 17th, 2022] [Originally Added On: July 17th, 2022]
- 013 EyePoint Pharmaceuticals Announces Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment... [Last Updated On: July 17th, 2022] [Originally Added On: July 17th, 2022]
- 014 What Are These Things Floating in Front of My Eyes? - The Epoch Times [Last Updated On: July 17th, 2022] [Originally Added On: July 17th, 2022]
- 015 Roche Wraps Week with a Bang, Touting Long-Term Breast Cancer, AMD Data - BioSpace [Last Updated On: July 17th, 2022] [Originally Added On: July 17th, 2022]
- 016 Myopic macular degeneration: What it is, and more - Medical News Today [Last Updated On: July 17th, 2022] [Originally Added On: July 17th, 2022]
- 017 Centrifuge Market: Increasing Prevalence of Infectious Diseases to Drive the Market - BioSpace [Last Updated On: August 3rd, 2022] [Originally Added On: August 3rd, 2022]
- 018 Babies born exposed to opioids and drugs need our support - GoErie.com [Last Updated On: August 3rd, 2022] [Originally Added On: August 3rd, 2022]
- 019 Gamma Probe Device Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2031 - BioSpace [Last Updated On: August 11th, 2022] [Originally Added On: August 11th, 2022]
- 020 New research digs into the genetic drivers of heart failure, with an eye to precision treatments - STAT [Last Updated On: August 11th, 2022] [Originally Added On: August 11th, 2022]
- 021 Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol - PR Newswire [Last Updated On: August 11th, 2022] [Originally Added On: August 11th, 2022]
- 022 New gene therapy to treat rare eye disease now available in Alberta ... [Last Updated On: December 28th, 2022] [Originally Added On: December 28th, 2022]
- 023 Eye floaters: What causes them, and what can you do? - Medical News Today [Last Updated On: December 28th, 2022] [Originally Added On: December 28th, 2022]
- 024 Eye care professional - Wikipedia [Last Updated On: December 28th, 2022] [Originally Added On: December 28th, 2022]
- 025 EMDR therapy: Everything you need to know - Medical News Today [Last Updated On: December 28th, 2022] [Originally Added On: December 28th, 2022]
- 026 Eye exercises for vertigo: Exercises to try at home - Medical News Today [Last Updated On: January 6th, 2023] [Originally Added On: January 6th, 2023]